Literature DB >> 27531529

Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis.

Aoife Kerrin1, Paul Fitch1,2, Claire Errington1, Dennis Kerr3, Liz Waxman4, Kay Riding3, Jon McCormack3, Felicity Mehendele3, Henry McSorley1, Karen MacKenzie1, Sabine Wronski5, Armin Braun5, Richard Levin4, Ulf Theilen2,3, Jürgen Schwarze1,2.   

Abstract

RATIONALE: The pathogenesis of respiratory syncytial virus (RSV) bronchiolitis in infants remains poorly understood. Mouse models implicate pulmonary T cells in the development of RSV disease. T cell responses are initiated by dendritic cells (DCs), which accumulate in lungs of RSV-infected mice. In infants with RSV bronchiolitis, previous reports have shown that DCs are mobilised to the nasal mucosa, but data on lower airway DC responses are lacking.
OBJECTIVE: To determine the presence and phenotype of DCs and associated immune cells in bronchoalveolar lavage (BAL) and peripheral blood samples from infants with RSV bronchiolitis.
METHODS: Infants intubated and ventilated due to severe RSV bronchiolitis or for planned surgery (controls with healthy lungs) underwent non-bronchoscopic BAL. Immune cells in BAL and blood samples were characterised by flow cytometry and cytokines measured by Human V-Plex Pro-inflammatory Panel 1 MSD kit.
MEASUREMENTS AND MAIN RESULTS: In RSV cases, BAL conventional DCs (cDCs), NK T cells, NK cells and pro-inflammatory cytokines accumulated, plasmacytoid DCs (pDCs) and T cells were present, and blood cDCs increased activation marker expression. When stratifying RSV cases by risk group, preterm and older (≥4 months) infants had fewer BAL pDCs than term born and younger (<4 months) infants, respectively.
CONCLUSIONS: cDCs accumulate in the lower airways during RSV bronchiolitis, are activated systemically and may, through activation of T cells, NK T cells and NK cells, contribute to RSV-induced inflammation and disease. In addition, the small population of airway pDCs in preterm and older infants may reveal a distinct endotype of RSV bronchiolitis with weak antiviral pDC responses. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Innate Immunity; Paediatric Lung Disaese; Respiratory Infection; Viral infection

Mesh:

Substances:

Year:  2016        PMID: 27531529     DOI: 10.1136/thoraxjnl-2015-207358

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.

Authors:  Cyril Le Nouën; Philippa Hillyer; Eric Levenson; Craig Martens; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Airway Epithelial Cell-Derived Colony Stimulating Factor-1 Promotes Allergen Sensitization.

Authors:  Hyung-Geun Moon; Seung-Jae Kim; Jong Jin Jeong; Seon-Sook Han; Nizar N Jarjour; Hyun Lee; Sherry L Abboud-Werner; Sangwoon Chung; Hak Soo Choi; Viswanathan Natarajan; Steven J Ackerman; John W Christman; Gye Young Park
Journal:  Immunity       Date:  2018-07-24       Impact factor: 31.745

Review 3.  The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management?

Authors:  Carlos E Rodríguez-Martínez; Jose A Castro-Rodriguez; Gustavo Nino; Fabio Midulla
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

Review 4.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 5.  Respiratory syncytial virus infection: an innate perspective.

Authors:  Cecilia Johansson
Journal:  F1000Res       Date:  2016-12-21

Review 6.  Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus.

Authors:  Karen Bohmwald; Janyra A Espinoza; Raúl A Pulgar; Evelyn L Jara; Alexis M Kalergis
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 7.  Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.

Authors:  Wendy Fonseca; Nicholas W Lukacs; Catherine Ptaschinski
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

8.  Toward Personalized Medicine in Bronchiolitis.

Authors:  Damián Alvarez Paggi; Fernando P Polack
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

Review 9.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

10.  Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.

Authors:  Elisabeth A van Erp; Dorien Feyaerts; Maxime Duijst; H Lie Mulder; Oliver Wicht; Willem Luytjes; Gerben Ferwerda; Puck B van Kasteren
Journal:  J Infect Dis       Date:  2019-02-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.